These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 29391506)
1. Therapeutic effects of anti-CD154 antibody in cynomolgus monkeys with advanced rheumatoid arthritis. Choi EW; Lee KW; Park H; Kim H; Lee JH; Song JW; Yang J; Kwon Y; Kim TM; Park JB; Kim S Sci Rep; 2018 Feb; 8(1):2135. PubMed ID: 29391506 [TBL] [Abstract][Full Text] [Related]
2. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis. Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921 [TBL] [Abstract][Full Text] [Related]
3. The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge. Ferrant JL; Benjamin CD; Cutler AH; Kalled SL; Hsu YM; Garber EA; Hess DM; Shapiro RI; Kenyon NS; Harlan DM; Kirk AD; Burkly LC; Taylor FR Int Immunol; 2004 Nov; 16(11):1583-94. PubMed ID: 15466914 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of CD23 hyperexpression on B cells from patients with rheumatoid arthritis. De Miguel S; Galocha B; Jover JA; Bañares A; Hernández-García C; García-Asenjo JA; Fernández-Gutiérrez B J Rheumatol; 2001 Jun; 28(6):1222-8. PubMed ID: 11409113 [TBL] [Abstract][Full Text] [Related]
5. Collagen-induced arthritis in nonhuman primates: multiple epitopes of type II collagen can induce autoimmune-mediated arthritis in outbred cynomolgus monkeys. Shimozuru Y; Yamane S; Fujimoto K; Terao K; Honjo S; Nagai Y; Sawitzke AD; Terato K Arthritis Rheum; 1998 Mar; 41(3):507-14. PubMed ID: 9506579 [TBL] [Abstract][Full Text] [Related]
6. A humanized anti-human CD154 monoclonal antibody blocks CD154-CD40 mediated human B cell activation. Brams P; Black A; Padlan EA; Hariharan K; Leonard J; Chambers-Slater K; Noelle RJ; Newman R Int Immunopharmacol; 2001 Feb; 1(2):277-94. PubMed ID: 11360929 [TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-α blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis. Tung CH; Lu MC; Lai NS; Wu SF PLoS One; 2017; 12(8):e0183726. PubMed ID: 28837666 [TBL] [Abstract][Full Text] [Related]
8. Effects of Transplantation of CTLA4Ig-Overexpressing Adipose Tissue-Derived Mesenchymal Stem Cells in Mice With Sustained Severe Rheumatoid Arthritis. Choi EW; Shin IS; Song JW; Lee M; Yun TW; Yang J; Choi KS; Kim SJ Cell Transplant; 2016; 25(2):243-59. PubMed ID: 26087385 [TBL] [Abstract][Full Text] [Related]
9. CD154 blockade, sirolimus, and donor-specific transfusion prevents renal allograft rejection in cynomolgus monkeys despite homeostatic T-cell activation. Pearl JP; Xu H; Leopardi F; Preston E; Kirk AD Transplantation; 2007 May; 83(9):1219-25. PubMed ID: 17496539 [TBL] [Abstract][Full Text] [Related]
10. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Toubi E; Shoenfeld Y Autoimmunity; 2004; 37(6-7):457-64. PubMed ID: 15621572 [TBL] [Abstract][Full Text] [Related]
11. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Durie FH; Fava RA; Foy TM; Aruffo A; Ledbetter JA; Noelle RJ Science; 1993 Sep; 261(5126):1328-30. PubMed ID: 7689748 [TBL] [Abstract][Full Text] [Related]
12. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives. Dejica DI; Manea EM Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of rheumatoid synovial cell interleukin-12 production by tumor necrosis factor alpha and CD40 signals. Kitagawa M; Mitsui H; Nakamura H; Yoshino S; Miyakawa S; Ochiai N; Onobori M; Suzuki H; Sumida T Arthritis Rheum; 1999 Sep; 42(9):1917-26. PubMed ID: 10513808 [TBL] [Abstract][Full Text] [Related]
14. Possible role of peripheral CD14low monocytes in the development of collagen-induced arthritis in cynomolgus monkeys (Macaca fascicularis). Terao K; Fujimoto K; Shimozuru Y; Nagai Y; Yoshikawa Y Exp Anim; 2001 Jan; 50(1):9-18. PubMed ID: 11326430 [TBL] [Abstract][Full Text] [Related]
15. Potent adjuvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma. Tellander AC; Michaëlsson E; Brunmark C; Andersson M J Autoimmun; 2000 Jun; 14(4):295-302. PubMed ID: 10882055 [TBL] [Abstract][Full Text] [Related]
18. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis. Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614 [TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of a novel therapeutic DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in normal rats. Juan L; Xiao Z; Song Y; Zhijian Z; Jing J; Kun Y; Yuna H; Dongfa D; Lili D; Liuxin T; Fei L; Nan L; Fang Y; Yuying S; Yongzhi X Hum Vaccin Immunother; 2015; 11(12):2777-83. PubMed ID: 26697972 [TBL] [Abstract][Full Text] [Related]